Initiator Pharma selects Clinical Site
Initiator Pharma, a Biotech Company developing a novel treatment of Erectile Dysfunction (ED), will be collaborating with MAC Clinical Research Early Phase Unit, an MHRA Accredited Unit in Manchester UK to complete their first clinical trial for drug candidate IPED2015.The Principal Investigator (PI) for this study will be Dr Peter Dewland BSc, MA, MBBS, FFPM, DCPSA. Dr Peter Dewland has had a career in Early Phase research which spans 40 years. During this time he has been Medical Director of several Phase 1 Organisations as well as Head of Clinical Pharmacology in major Pharma. During